Shuttle Pharmaceuticals Holdings, Inc. Common Stock

SHPHNASDAQ • USD
ThemeHealthcare - Oncology›Targeted Therapy & Precision Oncology
3.46 USD
↘ 0.91 (20.82%)AT CLOSE (11:59 AM EDT)
3.41
↘ 0.05 (1.56%)
POST MARKET (AS OF 07:58 PM EDT)
Post Market
AS OF 07:58 PM EDT
3.41
↘ 0.05 (1.56%)
🔴Market: CLOSED

Shares of Shuttle Pharmaceuticals Holdings, Inc. Common Stock (SHPH) are trading at $3.46. The stock presents a bearish profile across the board: technical indicators signal "Strong Sell" and our fundamental models agree with a "Sell" rating. Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On the valuation side, SHPH appears attractively valued relative to sector peers across key multiples.

Technical & fundamental data as of Jun 18, 2026.

Open?$3.88
High?$3.88
Low?$3.40
Prev. Close?$4.37
Volume?606.8K
Avg. Volume?1.3M
VWAP?$4.36
Rel. Volume?0.47x
Bid / Ask
Bid?$2.89 × 100
Ask?$4.11 × 100
Spread?$1.22
Midpoint?$3.50
Valuation & Ratios
Market Cap?2.0M
Shares Out?637.1K
Float?1.4M
Float %?87.4%
P/E Ratio?N/A
P/B Ratio?0.61
EPS?-$18.49
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Shuttle Pharmaceuticals Holdings Inc is a clinical-stage pharmaceutical company leveraging its proprietary technology to develop novel therapies designed to cure cancers. The company has one operating segment with a focus on the development of novel drug therapies, including cancer therapies, extending new applications of radiation therapy, and other drug development, including through the use of the Molecule.ai platform by the company as well as licensing the right to use Molecuile.ai to others. The company's goal is to extend the benefits of cancer treatments with surgery, radiation therapy, chemotherapy and immunotherapy. Radiation therapy (RT) is one of the effective modalities for treating cancers. Its pipeline includes: Ropidoxuridine, HDAC Inhibitors, PSMA-B, and PC-Rad Test.
Themes
Healthcare - Oncology›Targeted Therapy & Precision Oncology
Employees
2
Market Cap
2.0M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.shuttlepharma.com
Listed
2022-08-31
Address
401 PROFESSIONAL DRIVE
GAITHERSBURG, MD 20879
Phone: (240) 403-4212
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
77
Short Sent.?
54
Piotroski F-Score?0/9Weak
Altman Z-Score?-9.32Distress
Confidence?41%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?16.10%High
Short Interest?225.7K
Days to Cover?1.0
Free Float1.4M
Avg Daily Volume279.7K
Settlement Date2026-05-29
Financial Health
Current Ratio?0.30Weak
Quick Ratio?0.30Weak
Cash Ratio?0.13Low
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
Peers
100
S&P
97
0.61CHEAP▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-0.1CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
3
-323.4%WEAK▾
ROA?
S&P
3
-91.6%WEAK▾
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$934.6K
Fundamentals ratios updated end of day
MarketsMoversWatchlist